Cargando…
Higher-Dose DHA Supplementation Modulates Immune Responses in Pregnancy and Is Associated with Decreased Preterm Birth
Pregnancy and parturition involve extensive changes in the maternal immune system. In our randomized, multi-site, double-blind superiority trial using a Bayesian adaptive design, we demonstrated that 1000 mg/day of docosahexaenoic acid (DHA) was superior to 200 mg/day in preventing both early preter...
Autores principales: | Valentine, Christina J., Khan, Aiman Q., Brown, Alexandra R., Sands, Scott A., Defranco, Emily A., Gajewski, Byron J., Carlson, Susan E., Reber, Kristina M., Rogers, Lynette K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703393/ https://www.ncbi.nlm.nih.gov/pubmed/34959801 http://dx.doi.org/10.3390/nu13124248 |
Ejemplares similares
-
Assessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocol
por: Carlson, Susan E., et al.
Publicado: (2017) -
Higher dose docosahexaenoic acid supplementation during pregnancy and early preterm birth: A randomised, double-blind, adaptive-design superiority trial
por: Carlson, Susan E, et al.
Publicado: (2021) -
Personalized medicine enrichment design for DHA supplementation clinical trial
por: Lei, Yang, et al.
Publicado: (2017) -
DHA Supplementation Attenuates Inflammation-Associated Gene Expression in the Mammary Gland of Lactating Mothers Who Deliver Preterm
por: Adams, Joselyn M, et al.
Publicado: (2022) -
Subgroup identification of early preterm birth (ePTB): informing a future prospective enrichment clinical trial design
por: Zhang, Chuanwu, et al.
Publicado: (2017)